1Jones RN. An overview of the meropenem yearly susceptibility test information collection ( MYSTIC ) program: 1997-2004. Diagn Miembiol Infect Dis,2005,12:247-256 被引量：1
3Majumdar S, Kirby A, Berry N, et al.An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care tmit.J Hosp Infect,2004,58:160-161 被引量：1
4Higgins PG, Fluit AC, Milatovic D, et al.Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother, 2002,50: 299-301 被引量：1
5Mesaros N, Nordmann P, Plesiat P, et al. Pseudomonas aeruginosa:resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect, 2007,13 : 560-578 被引量：1
6Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect,2002,8: 321-331 被引量：1
7Wang C, Guo H. Inhibitor binding by metallo-beta-lactamase IMP-1 from Pseudomonas aeruginosa-quantum mechanical/ molecular mechanical simulations. Inteff Biophys, 2007, 111 : 9986-9992 被引量：1
8Toleman MA, Simm AM, Murphy TA, et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance program. Anfimierob Agents Chemother, 2002,50: 673-679 被引量：1
9Nehme D, Poole K. Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors. J Bacteriol, 2007,189:6118-6127 被引量：1
3Heydom A,Ersboll B,Kato J,et al.Statistical analysis of Pseudomonas aeruginosa biofilm development:impact of mutations in genes involved in twitching motility,cell-to-cell signaling,and stationary-phase sigma factor expression [J].Appl Envir Microbiol,200 被引量：1
4Bagge N,Ciofu O,Hentzer M,et al.Constitutive high expression of chromosomal β-Lactamase in Pseudomonas aeruginosa caused by a new insertion sequence located in ampD [J] Antimicrob Agents Chemother ,2002,46 (11):3406 被引量：1
5Mac Gowan AP,Bowker KE.Mechanism of fluoroquinolone resistance is an important factor in determining the antimicrobial effect of gemifloxacin against Streptococcus pneumoniae in an in vitro pharrnacokinetic model [J].Antimicrob Agents Chemother ,2003,47 ( 被引量：1
6Kureishi A,Diver JM,Beckthold B,et al.Cloning and nucleotide sequence of Pseudomonas aeruginosa gyrA gene from strain PAO1 and quinolone-resistant clinical isolates [J].Antimicrob Agents Chemother ,1994,38 (9):1944 被引量：1
7Takenouchi T,Sakagawa E,Sugawara M.Detection of gyrA mutations among 335 Pseudomonas aeruginosa stains isolated in Japan and their susceptibilities to fluoroquinolones[J].Antimicrob Agents Chemother ,1999,43(2) :406 被引量：1
8Stove CK,Pham QX,Erwin AL,et al.Complete genome sequence of Pseudomonas aeruginosa PAO1 an opportunistic pathogen [J].Nature,2000,406:959 被引量：1
9Poole K.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria [J].Antimicrob Agents Chemother,2000,44 (9):2233 被引量：1
10Masuda N,Ohya S.Cross-resistance to meropenem,cephems,and quinolones in Pseudomonas aeruginosa [J].Antimicrob Agents Chemother ,1992,36(9) :1847 被引量：1
